Sign In
Buy CRBU
$2.00
-0.320 (-13.79%)
At Close: Jun 03, 2026
Caribou Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Tuesday, 03'rd Jan 2023
BERKELEY, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz,
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates
06:48pm, Tuesday, 08'th Nov 2022
Caribou Biosciences, Inc. (CRBU) delivered earnings and revenue surprises of 8.33% and 8.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the s
Tradeweb Exchange-Traded Funds Update - September 2022
01:17pm, Friday, 14'th Oct 2022
Trading activity on the Tradeweb European ETF marketplace amounted to EUR 49.7 billion in September. Total consolidated U.S. ETF notional value traded in September 2022 reached USD 51 billion.
Caribou Biosciences: Strong Momentum Possible If Higher Dose Shows Durability
07:18am, Wednesday, 12'th Oct 2022
Caribou Biosciences' early data was good, but not that durable. However, this was the lowest dose cohort, and safety was manageable.
Valneva, Take-Two Interactive And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
11:24am, Monday, 19'th Sep 2022 Benzinga
U.S. stock futures traded lower this morning after recording losses last week. Here are some big stocks moving lower in today’s pre-market trading session.
SoundHound AI, Inc. (NASDAQ: SOUN) shares
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
10:53am, Monday, 19'th Sep 2022 Benzinga
Gainers
FOXO Technologies Inc. (NYSE: FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday.
Amprius Technologies, Inc. (NYSE: AMPX) shares rose 20.5% to $10.00 in pre-market t
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
05:53am, Monday, 19'th Sep 2022 Benzinga
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares climbed 50.4% to settle at $3.76 on Friday after
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session
04:38pm, Friday, 16'th Sep 2022 Benzinga
Gainers
Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares jumped 32.4% to $3.31 after the
This Biotech Stock Could Offer Big Growth – Even During A Recession
12:03pm, Saturday, 03'rd Sep 2022 The Motley Fool
Caribou Biosciences is the biotech behind some cutting-edge cancer therapies
This Biotech Stock Could Offer Big Growth – Even During A Recession
08:03am, Saturday, 03'rd Sep 2022
Caribou Biosciences is the biotech behind some cutting-edge cancer therapies
Caribou Biosciences to Participate in Upcoming Investor Conferences
08:05pm, Wednesday, 31'st Aug 2022 GlobeNewswire Inc.
BERKELEY, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’
Caribou Biosciences to Participate in Upcoming Investor Conferences
04:05pm, Wednesday, 31'st Aug 2022
BERKELEY, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company's pa
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
06:14pm, Thursday, 18'th Aug 2022 Benzinga
Last week, Caribou Biosciences Inc (NASDAQ: CRBU) announced Q2 earnings and provided updated results from the Phase 1 ANTLER trial of the company's lead asset—CB-010 for relapsed or refractory B
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates
09:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Caribou Biosciences, Inc. (CRBU) delivered earnings and revenue surprises of -24.32% and 48.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the sto
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Tuesday, 09'th Aug 2022
Caribou Biosciences, Inc. (CRBU) delivered earnings and revenue surprises of -24.32% and 48.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the sto
